Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Infectious Mononucleosis 1Glioblastoma 1Epstein-Barr Virus Infections 1

Interventions

pembrolizumab 2Rituximab 2valomaciclovir 1threonic acid 1otelixizumab 1brincidofovir 1Valganciclovir 1Valacyclovir 1Tenofovir 1N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1Matrix-M 1Magnesium Sulfate 1Lenalidomide 1Brentuximab Vedotin 1Bevacizumab 13-(4-chlorophenyl)-adamantane-1-carboxylic acid (pyridin-4-ylmethyl)amide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Epstein-Barr Virus Infections × Valacyclovir × Clear all
NCT00274404 2011-10-27

Controlled Trial of Valacyclovir in Infectious Mononucleosis

University of Minnesota

Phase 1/2 Completed
20 enrolled

Infectious Mononucleosis, Epstein-Barr Virus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡